HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…
September 12, 2025 16:30 ET | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics,…
September 12, 2025 07:00 ET | Source: Cullinan Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics,…
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the Hong Kong Department of Health has…
Celebrates Indian Independence Day by Honoring the US-India Innovation PartnershipCAMBRIDGE, Mass.--(BUSINESS WIRE)--$HIND--Vyome Holdings (Nasdaq: HIND), a clinical-stage healthcare holding company…
Thursday 31 July, 2025 FLIT, the Cambridge-based ebike developer, has released a new video showcasing its latest folding ebike, the…
CAMBRIDGE, Mass., June 25, 2025 /PRNewswire/ -- A new survey report by MIT Technology Review Insights reveals the best practices for…
July 04, 2025 03:00 ET | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…
CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- ReversingLabs, the trusted name in file and software security, today announced it…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Datalign Advisory launched GEOs, an AI-powered geographic expansion engine to help financial advisors identify underserved consumers. GEOs uses…